Description

Bevacizumab 100mg. amp
Bevacizumab es un anticuerpo dirigido al factor de crecimiento endotelial vascular. Bevacizumab es un anticuerpo monoclonal IgG1 humanizado recombinante que contiene regiones estructurales humanas y regiones determinantes de complementariedad murinas. Bevacizumab tiene un peso molecular aproximado de 149 kDa. Bevacizumab se produce en un sistema de expresión de células de mamíferos (ovario de hámster chino).

La inyección de bevacizumab para uso intravenoso es una solución estéril, de transparente a ligeramente opalescente, de incolora a marrón pálida.

La forma de marca de “Avastin” se suministra en viales de dosis única sin conservantes de 100 mg y 400 mg para administrar 4 ml o 16 ml de Avastin (25 mg/m2L).

-El producto de 100mg está formulado en 240 mg de α,α-trehalosa dihidrato, 23,2 mg de fosfato de sodio (monobásico, monohidrato), 4,8 mg de fosfato de sodio (dibásico, anhidro), 1,6 mg de polisorbato 20 y agua para inyección, USP.

Precios de marca AVASTIN: U$D 3,366.21
Nuestro precio genérico Bevacizumab: U$D 291.00

===========
Bevacizumab is an antiangiogenic drug used to treat a certain type of brain tumor as well as cancers of the kidney, colon, rectum, lung, or breast. Bevacizumab is usually given as part of a combination of cancer medicines.

Bevacizumab is vascular endothelial growth factor directed antibody. Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system.

Bevacizumab injection for intravenous use is a sterile, clear to slightly opalescent, colorless to pale brown solution.

The brand form of “Avastin” is supplied in 100 mg and 400 mg preservative-free, single-dose vials to deliver 4 mL or 16 mL of Avastin (25 mg/m2L).

-The 100 mg product is formulated in 240 mg α,α-trehalose dihydrate, 23.2 mg sodium phosphate (monobasic, monohydrate), 4.8 mg sodium phosphate (dibasic, anhydrous), 1.6 mg polysorbate 20, and Water for Injection, USP.

-The 400 mg product is formulated in 960 mg α,α-trehalose dihydrate, 92.8 mg sodium phosphate (monobasic, monohydrate), 19.2 mg sodium phosphate (dibasic, anhydrous), 6.4 mg polysorbate 20, and Water for Injection, USP.